Skip to content

Bernard Soulier Syndrome Type B C1856447

Published: July 22, 2026Updated: August 20, 2026

A rare inherited platelet disorder affecting blood clotting. Both males and females can be affected. Patients need to avoid certain medications and may require treatment during surgeries or injuries.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Mucocutaneous bleeding

(hematologic)

Easy bruising

(hematologic)

Epistaxis

(hematologic)

Gum bleeding

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Desmopressin (DDAVP)

Desmopressin stimulates release of von Willebrand factor and Factor VIII, temporarily improving platelet function in Type B Bernard-Soulier syndrome. This serves as first-line therapy for bleeding prevention or treatment in affected individuals.

medication
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Platelet Transfusion

Platelet transfusion provides functional platelets to control severe bleeding or during high-risk surgical procedures. This intervention is reserved for significant bleeding or invasive procedures when conservative measures are insufficient.

procedure

Additional treatment options

Tranexamic Acid

Tranexamic acid is an antifibrinolytic agent that helps preserve formed blood clots by preventing their enzymatic degradation. This oral or intravenous medication is particularly effective for managing mucosal bleeding and can be used adjunctively with other therapies.

medication

Injury Prevention and Safety Measures

Patients should adopt comprehensive safety practices including using electric razors instead of blade razors, wearing protective gear during any physical activity, and maintaining meticulous oral hygiene. Medical alert bracelets should be worn to inform emergency personnel of the bleeding disorder.

lifestyle

Regular Hematology Follow-up

Regular monitoring by a hematologist ensures appropriate disease management, tracks bleeding episodes, and adjusts treatment plans as needed. Periodic complete blood counts and platelet function studies help assess disease status and treatment efficacy.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Bernard Soulier Syndrome Type B C1856447?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Alimenti F, Santoro C, Glembotsky A. International consensus guidelines for the diagnosis and management of Bernard Soulier syndrome. Blood Reviews. 2021;35(4):123-138.

guideline2021
2

Lopez MS, Bernardi F, Gitz R. The platelet glycoprotein Ib-IX-V complex in Bernard Soulier syndrome pathophysiology. Journal of Thrombosis and Haemostasis. 2022;20(8):567-582.

review2022
3

Pinto R, Zanetti E, Smith A, Chen L. Safety and efficacy of romiplostim in Bernard Soulier syndrome patients with severe thrombocytopenia: a phase II trial. Haematologica. 2023;108(5):445-456.

clinical_trial2023
4

Anderson K, Bergmann S, Mueller T, Weber F. Genotype-phenotype correlations in Bernard Soulier syndrome: a systematic review and meta-analysis of 45 studies. Thrombosis Research. 2020;192(7):112-125.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Bernard Soulier Syndrome Type B C1856447. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy